Anti-PD-1 Antibody (Gresonitamab)
Catalog No.
F2107
Anti-PD-1 Antibody (Gresonitamab)
Featured Products
Gresonitamab is a monoclonal antibody derived from humanized antibody technology. Its composition mainly includes heavy and light chains of the IgG1 subtype. Gresonitamab specifically binds to the target molecule PD-1, blocking the interaction between PD-1 and its ligands PD-L1 and PD-L2, thereby restoring the anti-tumor activity of T cells. The drug is mainly used to treat certain types of cancer, such as non-small cell lung cancer and melanoma.
Dry ice
2413817-97-5
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AMG 910, Anti-Human CD3xClaudin18.2
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
PD-1
Please avoid freeze-thaw cycles.